Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CMV PED Study - A Retrospective Observational Study To Understand The Clinical And Economic Burden Associated With Cytomegalovirus Reactivation and Related Health Outcomes In Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation In Italy

NCT06916195 is registered in ClinicalTrials.gov with MSD Italia S.r.l. as lead sponsor.

NCT NCT06916195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06916195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CMV PED Study - A Retrospective Observational Study To Understand The Clinical And Economic Burden Associated With Cytomegalovirus Reactivation and Related Health Outcomes In Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation In Italy
Lead sponsor
MSD Italia S.r.l.
Phase
Observational
Overall status
Recruiting
Start date
May 9, 2025
Completion date
July 15, 2026
Enrollment
230 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infection, hematopoietic stem cells transplantation